Building a Successful Research-Driven COVID-19 Testing Program: Results From an Academic–School Partnership-Reference-Cited by-同舟云学术

Building a Successful Research-Driven COVID-19 Testing Program: Results From an Academic–School Partnership

Published:2024-05 Issue:S5 Volume:114 Page:S384-S387
ISSN:0090-0036
Container-title:American Journal of Public Health
language:en
Short-container-title:Am J Public Health

Author:

Dozier Ann M.¹,Zandi Karen¹,Pawlowski Anne¹,Ross Alexis¹,Spallina Samantha¹,Holden-Wiltse Jeanne¹,Cameron Andrew¹,Freedman Edward G.¹,Seplaki Christopher L.¹,Dewhurst Stephen¹,Zand Martin¹,Foxe John J.¹

Affiliation:

1. Ann M. Dozier, Samantha Spallina, Jeanne Holden-Wiltse, Andrew Cameron, Edward G. Freedman, Christopher L. Seplaki, Stephen Dewhurst, Martin Zand, and John J. Foxe are with the University of Rochester, Rochester, NY. Karen Zandi, Anne Pawlowski, and Alexis Ross are with the Mary Cariola Center, Rochester, NY.

Abstract

An academic partnership between a university and an upstate New York school serving students with intellectual and developmental disabilities established a research-driven, weekly onsite asymptomatic COVID-19 testing protocol supplemented by symptomatic testing. The research team, including school leadership, met at least weekly to address implementation issues, impacts of changing pandemic and regulatory requirements, and interpretation and dissemination of findings. The dynamic partnership resulted in 380 participants, more than 16 000 polymerase chain reaction tests, and additional research studies. ( Am J Public Health. 2024;114(S5):S384–S387. https://doi.org/10.2105/AJPH.2024.307687 )

Publisher

American Public Health Association

Link

https://ajph.aphapublications.org/doi/pdf/10.2105/AJPH.2024.307687

Reference7 articles.

1. Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis

2. Children with disabilities in the United States and the COVID-19 pandemic

3. COVID-19 mortality burden and comorbidity patterns among decedents with and without intellectual and developmental disability in the US

4. Recommendations for SARS-CoV-2 Testing in Children With Disabilities and Medical Complexity